Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

Yeti Holdings (YETI) - Get Report : "I like Yeti very much."

Canopy Growth (CGC) - Get Report : "That's the only one I'm recommending."

Dermira (DERM) - Get Report : "I think this one is for speculation only. I can't get too excited about this one."

Daktronics (DAKT) - Get Report : "No, I haven't liked that one in years."

TherapeuticsMD (TXMD) - Get Report : "Ouch. I'm done with this one."

Rite Aid (RAD) - Get Report : "No, no. There's not that much there."

Genpact (G) - Get Report : "They tell a great story."

California Water Service (CWT) - Get Report : "I don't want anything to do with California regulations right now."

Cramer and the AAP team have updates on two portfolio names: CVS Health (CVS) - Get Report and Facebook (FB) - Get Report . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts Plus.

On Real Money, Jim Cramer takes a closer look at Salesforce's deal for Tableau. Get more of his insights with a free trial subscription to Real Money.

Introducing TheStreet Courses: Financial titans Jim Cramer and Robert Powell are bringing their market savvy and investing strategies to you. Learn how to create tax-efficient income, avoid top mistakes, reduce risk and more. With our courses, you will have the tools and knowledge needed to achieve your financial goals. Learn more about TheStreet Courses on investing and personal finance here.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in CVS, FB.